Literature DB >> 24682890

Acute revascularization in ST-segment-elevation myocardial infarction.

Petko Prodanov1, Petr Widimsky.   

Abstract

We briefly and comprehensively present some of the novel findings in the field of revascularization therapy and management of ST-segment-elevation myocardial infarction (STEMI). We highlight the latest evidence-based advancements in the pharmacological and mechanical treatment of patients who presented with STEMI. Since the last updates to the international guidelines (American College of Cardiology/American Heart Association and the European Society of Cardiology) were published in 2011 and 2012, there have been changes and several important studies have presented their final outcomes. We also highlight some controversial approaches as part of the current debates in the cardiology community. In addition, we share our recent experience in the field of biodegradable scaffold stents as a treatment strategy in STEMI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24682890     DOI: 10.1007/s11883-014-0412-6

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  38 in total

1.  Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.

Authors:  Mustafa Toma; Christopher E Buller; Cynthia M Westerhout; Yuling Fu; William W O'Neill; David R Holmes; Christian W Hamm; Christopher B Granger; Paul W Armstrong
Journal:  Eur Heart J       Date:  2010-06-08       Impact factor: 29.983

2.  A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction.

Authors:  Christophe Loubeyre; Marie-Claude Morice; Thierry Lefèvre; Jean-François Piéchaud; Yves Louvard; Pierre Dumas
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

3.  Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Authors:  Deepak L Bhatt; Gregg W Stone; Kenneth W Mahaffey; C Michael Gibson; P Gabriel Steg; Christian W Hamm; Matthew J Price; Sergio Leonardi; Dianne Gallup; Ezio Bramucci; Peter W Radke; Petr Widimský; Frantisek Tousek; Jeffrey Tauth; Douglas Spriggs; Brent T McLaurin; Dominick J Angiolillo; Philippe Généreux; Tiepu Liu; Jayne Prats; Meredith Todd; Simona Skerjanec; Harvey D White; Robert A Harrington
Journal:  N Engl J Med       Date:  2013-03-10       Impact factor: 91.245

4.  Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea registries.

Authors:  Kyung Woo Park; Joo Myung Lee; Si-Hyuck Kang; Hyo-Suk Ahn; Han-Mo Yang; Hae-Young Lee; Hyun-Jae Kang; Bon-Kwon Koo; Janghyun Cho; Hyeon-Cheol Gwon; Sung Yoon Lee; In-Ho Chae; Tae-Jin Youn; Jei Keon Chae; Kyoo-Rok Han; Cheol Woong Yu; Hyo-Soo Kim
Journal:  J Am Coll Cardiol       Date:  2012-12-26       Impact factor: 24.094

5.  Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

Authors:  Eugenia Nikolsky; Brent T McLaurin; David A Cox; Steven V Manoukian; Ke Xu; Roxana Mehran; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2012-09       Impact factor: 11.195

6.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

7.  Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.

Authors:  Philippe Gabriel Steg; Stefan James; Robert A Harrington; Diego Ardissino; Richard C Becker; Christopher P Cannon; Håkan Emanuelsson; Ariel Finkelstein; Steen Husted; Hugo Katus; Jan Kilhamn; Sylvia Olofsson; Robert F Storey; W Douglas Weaver; Lars Wallentin
Journal:  Circulation       Date:  2010-11-08       Impact factor: 29.690

Review 8.  The state of periprocedural antiplatelet therapy after recent trials.

Authors:  Nihar R Desai; Deepak L Bhatt
Journal:  JACC Cardiovasc Interv       Date:  2010-06       Impact factor: 11.195

Review 9.  Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials.

Authors:  Kyung Woo Park; Si-Hyuck Kang; Matthijs A Velders; Dong-Ho Shin; Seokyung Hahn; Woo-Hyun Lim; Han-Mo Yang; Hae-Young Lee; Adrianus J Van Boven; Sjoerd H Hofma; Hyun-Jae Kang; Bon-Kwon Koo; Byung-Hee Oh; Young-Bae Park; David E Kandzari; Hyo-Soo Kim
Journal:  Am Heart J       Date:  2012-12-27       Impact factor: 4.749

Review 10.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.